ADHD guideline update: What’s new, what’s changed
The update to the clinical practice guidelines is the first since 2011, and changes focus on the evaluation, diagnosis, and treatment of ADHD in children aged 4 to 18 years. Although there are no major changes to how ADHD is managed, the guidelines highlight the need to address issues that the child may be experiencing outside of ADHD, such as learning and language disorders, anxiety, depression, and autism.
Other Articles in this Edition
Kids with heart rhythm problems more likely to have ADHD, anxiety and depression
No Increased CVD Event Risk With ADHD Meds in Kids With Autism
Treating ADHD by Monitoring Brainwaves While Children Play a Video Game
ADHD guideline update: What’s new, what’s changed
Supernus Pharmaceuticals seeks FDA approval for ADHD drug